On April 9, 2025 Cellis reported that it will be present at the upcoming AACR (Free AACR Whitepaper) Annual Meeting, taking place April 25–30 in Chicago, where leaders in oncology research gather to shape the future of cancer treatment (Press release, Cellis, APR 9, 2025, View Source [SID1234651849]). We’re proud to contribute to this global conversation with new developments in macrophage-based therapies.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

We invite you to visit our three poster presentations:

PO.ET02.08
Harnessing macrophage-drug conjugates for allogeneic cell-based therapy of solid tumors
April 28, 9:00 AM – 12:00 PM | Section 23

PO.CL06.01
Macrophage-ferritin-drug conjugates: a novel approach to overcome glioblastoma drug resistance and induce long-term tumor immunity
April 28, 2:00 PM – 5:00 PM | Section 27

PO.IM01.16
Macrophage-based immunotherapy of platinum-resistant ovarian cancer
April 29, 2:00 PM – 5:00 PM | Section 40

We look forward to insightful discussions and potential collaborations in Chicago.